Triple

T4220723
Position Surface form Disambiguated ID Type / Status
Subject National Center for Advancing Translational Sciences E94332 entity
Predicate abbreviation P43 FINISHED
Object NCATS E16877 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: NCATS | Statement: [National Center for Advancing Translational Sciences, abbreviation, NCATS]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: NCATS
Context triple: [National Center for Advancing Translational Sciences, abbreviation, NCATS]
  • A. National Center for Advancing Translational Sciences chosen
    The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
  • B. National Center for Toxicological Research
    The National Center for Toxicological Research is a U.S. federal research facility that conducts scientific studies to support the safety evaluation and regulatory decisions of the Food and Drug Administration.
  • C. Center for Scientific Review
    The Center for Scientific Review is the National Institutes of Health component responsible for overseeing the peer review of most grant applications to ensure scientific merit and integrity in funding decisions.
  • D. Center for Biologics Evaluation and Research
    The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
  • E. National Institutes of Health
    The National Institutes of Health is the United States’ primary federal biomedical research agency, supporting and conducting medical research to improve public health.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69b3451997e08190851db4a9a588837d completed March 12, 2026, 10:58 p.m.
NER Named-entity recognition batch_69b34e0c84548190b051d32d434cbf04 completed March 12, 2026, 11:36 p.m.
NED1 Entity disambiguation (via context triple) batch_69b5a858a5b08190990a896265ac9725 completed March 14, 2026, 6:26 p.m.
Created at: March 12, 2026, 11:04 p.m.